Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical silver-nimesulide complex for cutaneous squamous cell carcinoma
RBR-3csjgb8Phase 2Not yet recruiting
- Sponsor
- Universidade Estadual de Campinas
- Start
- Mar 2026
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in cutaneous squamous cell carcinoma (cSCC), sponsored by Universidade Estadual de Campinas. Primary endpoint: Safety and local tolerability. Planned start Mar 2026; status: not yet recruiting.
02
Conditions
cutaneous squamous cell carcinoma (cSCC)
Beyond the preview
Go deeper on RBR-3csjgb8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-3csjgb8.